Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-10 10:42 am Sale | 13G | Eli Lilly and Company LLY | PNC FINANCIAL SERVICES GROUP INC. PNC | 51,829,873 5.25% | -58,582 (-0.11%) | View |
| 2023-02-09 11:19 am Purchase | 13G | Eli Lilly and Company LLY | VANGUARD GROUP INC | 73,429,863 7.73% | 4,168,109 (+6.02%) | View |
| 2023-01-31 5:52 pm Purchase | 13G | Eli Lilly and Company LLY | BlackRock Inc. BLK | 65,467,793 6.9% | 1,590,770 (+2.49%) | View |
| 2023-01-27 4:57 pm Unchanged | 13G | Precision BioSciences, Inc. DTIL | ELI LILLY & Co LLY | 3,762,190 3.4% | 0 (Unchanged) | View |
| 2023-01-27 4:41 pm Unchanged | 13G | AC Immune SA ACIU | ELI LILLY & Co LLY | 3,615,328 4.3% | 0 (Unchanged) | View |
| 2023-01-25 4:14 pm Sale | 13G | Eli Lilly and Company LLY | LILLY ENDOWMENT INC | 102,948,810 10.83% | -4,515,000 (-4.20%) | View |
| 2022-12-23 4:39 pm Purchase | 13G | ProQR Therapeutics N.V. PRQR | ELI LILLY & Co LLY | 13,371,562 16.6% | 9,381,586 (+235.13%) | View |
| 2022-12-01 4:11 pm Sale | 13D | Akouos Inc. AKUS | ELI LILLY & Co LLY | 100 100% | -9,639,089 (-100.00%) | View |
| 2022-10-27 4:31 pm Purchase | 13D | Akouos Inc. AKUS | ELI LILLY & Co LLY | 9,639,189 25.5% | 9,639,189 (New Position) | View |
| 2022-02-11 07:46 am Sale | 13G | Eli Lilly and Company LLY | PNC FINANCIAL SERVICES GROUP INC. PNC | 51,888,455 5.42% | -123,696 (-0.24%) | View |
| 2022-02-10 4:29 pm Purchase | 13G | Forma Therapeutics Holdings Inc. FMTX | ELI LILLY & Co LLY | 339,191 0.7% | 339,191 (New Position) | View |
| 2022-02-10 4:26 pm Purchase | 13G | Surface Oncology, Inc. SURF | ELI LILLY & Co LLY | 1,593,997 3.5% | 1,593,997 (New Position) | View |
| 2022-02-10 4:21 pm Unchanged | 13G | Avidity Biosciences, Inc. RNA | ELI LILLY & Co LLY | 2,319,396 4.9% | 0 (Unchanged) | View |
| 2022-02-10 4:16 pm Purchase | 13G | Leap Therapeutics, Inc. LPTX | ELI LILLY & Co LLY | 3,151,605 3.5% | 519,384 (+19.73%) | View |
| 2022-02-10 4:13 pm Sale | 13G | Aeglea BioTherapeutics, Inc. AGLE | ELI LILLY & Co LLY | 1,526,516 3.1% | -1,042,027 (-40.57%) | View |
| 2022-02-10 4:05 pm Purchase | 13G | Immunocore Holdings plc IMCR | ELI LILLY & Co LLY | 2,548,145 5.8% | 2,548,145 (New Position) | View |
| 2022-02-09 3:43 pm Purchase | 13G | Eli Lilly and Company LLY | VANGUARD GROUP INC | 69,261,754 7.24% | 600,260 (+0.87%) | View |
| 2022-02-08 5:12 pm Purchase | 13G | Eli Lilly and Company LLY | BlackRock Inc. BLK | 63,877,023 6.7% | 5,065,255 (+8.61%) | View |
| 2022-01-27 4:56 pm Sale | 13G | Eli Lilly and Company LLY | LILLY ENDOWMENT INC | 107,463,810 11.23% | -3,668,533 (-3.30%) | View |
| 2021-12-13 08:16 am Purchase | 13G | Foghorn Therapeutics Inc. FHTX | ELI LILLY & Co LLY | 4,000,000 9.7% | 4,000,000 (New Position) | View |